Targeting BRCAness in Gastric Cancer
Abstract
We have made substantial progress in the projects goals. We have set up a system (described below) to interrogate gastric cancer cells with ATR and PARP inhibitors. This screening platform is now up and running and we are prosecuting preliminary hits.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2020
- Accession Number
- AD1097364
Entities
People
- Yelena Janjigian
Organizations
- Sloan-Kettering Institute